Abound Wealth Management’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-13
Closed -$372 1381
2023
Q4
$372 Buy
13
+2
+18% +$59 ﹤0.01% 1056
2023
Q3
$408 Hold
11
﹤0.01% 875
2023
Q2
$430 Buy
+11
New +$431 ﹤0.01% 901

Other funds holding RTO

Abound Wealth Management's RTO Position: Q1 2024 in Review

Abound Wealth Management sold out of Rentokil (RTO) in Q1 2024, closing a stake of 13 shares — an estimated $372 sold.

Abound Wealth Management first reported a position in RTO in Q2 2023 and held it in 3 quarters. The position peaked at $430 in Q2 2023. 228 funds tracked by Wall St. Rank hold RTO as of Q1 2024.

  • Abound Wealth Management reported no remaining Rentokil position as of Q1 2024 after selling out during the quarter.
  • Abound Wealth Management sold 13 Rentokil shares in Q1 2024, an estimated $372.
  • Abound Wealth Management first reported a position in Rentokil in Q2 2023 and held it in 3 quarters.
  • Abound Wealth Management's Rentokil position peaked at $430 in Q2 2023.
  • 228 funds tracked by Wall St. Rank held Rentokil as of Q1 2024.

Based on Abound Wealth Management's 13F filing for Q1 2024, filed 8 Aug 2024.